{
    "organizations": [],
    "uuid": "a9d150aec805ac6e0a0adbb9ec7390e2dcfdb868",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novo-says-semaglutide-reduces-bloo/brief-novo-says-semaglutide-reduces-blood-sugar-and-weight-more-than-dulaglutide-idUSFWN1PR0AH",
    "ord_in_thread": 0,
    "title": "BRIEF-Novo Says ‍Semaglutide Reduces Blood Sugar And Weight More Than Dulaglutide​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1 (Reuters) - NOVO NORDISK:\n* SAYS ‍SEMAGLUTIDE DEMONSTRATED SIGNIFICANT REDUCTIONS IN BLOOD SUGAR AND WEIGHT COMPARED WITH DULAGLUTIDE​\n* SAYS SUSTAIN 7 TRIAL SHOWED THAT PEOPLE WITH TYPE 2 DIABETES TREATED WITH ONCE-WEEKLY SEMAGLUTIDE EXPERIENCED STATISTICALLY GREATER REDUCTIONS IN HBA1C AND BODY WEIGHT COMPARED TO TREATMENT WITH DULAGLUTIDE​\n* SAYS SUSTAIN 7 TRIAL SHOWED ‍FROM A MEAN BASELINE OF 95.2 KG, BODY WEIGHT WAS REDUCED BY 4.6 KG IN PEOPLE TREATED WITH SEMAGLUTIDE 0.5 MG COMPARED WITH 2.3 KG IN PEOPLE TREATED WITH DULAGLUTIDE 0.75 MG​ Further company coverage: (Copenhagen newsroom)\n ",
    "published": "2018-02-01T16:42:00.000+02:00",
    "crawled": "2018-02-02T12:46:40.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "novo",
        "nordisk",
        "say",
        "demonstrated",
        "significant",
        "reduction",
        "blood",
        "sugar",
        "weight",
        "compared",
        "say",
        "sustain",
        "trial",
        "showed",
        "people",
        "type",
        "diabetes",
        "treated",
        "semaglutide",
        "experienced",
        "statistically",
        "greater",
        "reduction",
        "hba1c",
        "body",
        "weight",
        "compared",
        "treatment",
        "say",
        "sustain",
        "trial",
        "showed",
        "mean",
        "baseline",
        "kg",
        "body",
        "weight",
        "reduced",
        "kg",
        "people",
        "treated",
        "semaglutide",
        "mg",
        "compared",
        "kg",
        "people",
        "treated",
        "dulaglutide",
        "company",
        "coverage",
        "copenhagen",
        "newsroom"
    ]
}